Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
Comments requested: Safety Evaluation Study Design
Moderator(s):
Page 1 of 1
Thread Actions

7/21/2015 at 1:35:19 PM GMT
Posts: 4
Comments requested: Safety Evaluation Study Design

The members of the “Standardisation of post-registration surveillance” project group drafted a minimal data collection scheme starting from the analysis of the available registries/databases. It aims at collecting information on safety on patients using standard or new drugs in order to carry on a post marketing surveillance. This document contains questions related to the period of post-registration study and also to a second longer period of observation. The first part should last 100 ED using the inhibitor testing schedule currently required by EMA for all patients who start to use a new product. The second part is the collection of information of any adverse event, i.e. every 6 months for a longer period of time (1-3 years or for the entire life of patients). We would like to receive comments from scientific community.

Please see the attached documents and make comments on this post.


 Attached Files:  ,

Membership Management Software Powered by YourMembership  ::  Legal
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.